|
2024
|
Invention
|
Piperidine substituted compounds as muscarinic m4 receptor positive allosteric modulators (m4 pam... |
|
|
Invention
|
Heteroaromatic compounds as muscarinic m4 receptor positive allosteric modulators (m4 pams). The ... |
|
|
Invention
|
N-aryl benzamide derivatives as p2x7 receptor antagonists. The present invention relates to novel... |
|
|
Invention
|
Method of treating cognitive deficits associated with schizophrenia.
The present invention relat... |
|
|
Invention
|
New uses of a 5-ht4 receptor agonist.
The present invention relates to new uses of a 5-HT4 recep... |
|
2023
|
Invention
|
Heteroaromatic compounds for the treatment of neurological disorders |
|
|
Invention
|
Heteroaromatic compounds for the treatment of neurological disorders. 2A1A1A receptor. The presen... |
|
|
Invention
|
Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disorders.
The present... |
|
|
Invention
|
Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disorders. The present ... |
|
|
Invention
|
Heteroalicyclic derivatives and their use in the treatment of cns disorders.
The present inventi... |
|
|
Invention
|
Heteroalicyclic derivatives and their use in the treatment of cns disorders. The present inventio... |
|
|
Invention
|
Pyrrolo[1,2-b]-2-pyridazinone compounds as 5-ht4 receptor agonists. 4 receptor agonists. The pres... |
|
|
Invention
|
4 receptor agonists. 44 receptor agonists. The present invention also describes methods of making... |
|
|
Invention
|
Pyrrolo[1,2-b]-2-pyridazinone compounds as 5-ht4 receptor agonists. The present invention relates... |
|
2021
|
Invention
|
Pharmaceutical compositions of 5-ht6 receptor antagonist.
The present invention relates to an im... |
|
2020
|
Invention
|
Methods for treating behavioral and psychological symptoms in patients with dementia.
The presen... |
|
|
Invention
|
Treating behavioral and psychological symptoms in dementia patients.
The present invention provi... |
|
|
Invention
|
Methods for treating behavioral and psychological symptoms in patients with dementia. The present... |
|
|
Invention
|
Treating behavioral and psychological symptoms in dementia patients. The present invention provid... |
|
|
Invention
|
Methods for treating behavioral and psychological symptoms in patients with dementia. 666 recepto... |
|
|
Invention
|
Treating behavioral and psychological symptoms in dementia patients. 66 receptor antagonist, masu... |
|
|
Invention
|
Prodrugs of abiraterone. The present invention relates to compounds of formula (I), or their isot... |
|
|
Invention
|
Amorphous pharmaceutical compositions of abiraterone acetate.
The present invention relates to a... |
|
|
Invention
|
Amorphous pharmaceutical compositions of abiraterone acetate. The present invention relates to a ... |
|
2019
|
Invention
|
Uses of a 5-ht4 receptor agonist. 4 receptor agonist, specifically Isopropyl-3-{5-[1-(3-methoxypr... |
|
|
Invention
|
New uses of a 5-ht4 receptor agonist. The present invention relates to new uses of a 5-HT4 recept... |
|
|
Invention
|
Pyrrolo-pyridazine derivatives as muscarinic m1 receptor positive allosteric modulators. The pres... |
|
2018
|
Invention
|
Substituted azacycles as muscarinic m1 receptor positive allosteric modulators. The present inven... |
|
|
Invention
|
Polycyclic amides as muscarinic m1 receptor positive allosteric modulators. The present invention... |
|
|
Invention
|
Polycyclic amides as muscarinic m1 receptor positive allosteric modulators. The present inv... |
|
|
Invention
|
Heteroaryl compounds as muscarinic m1 receptor positive allosteric modulators. The present invent... |
|
|
Invention
|
Fluoropiperidine compounds as pure 5-ht 6 receptor antagonists. The present invention relates to ... |
|
|
Invention
|
Method of treatment with histamine-3 receptor inverse agonist. The present invention provides new... |
|
|
Invention
|
New uses of a pure 5-ht 6 receptor antagonist.
The present invention relates to new uses of a pu... |
|
2017
|
Invention
|
Pharmaceutical compositions of 5-ht6 antagonist.
The present invention relates to an immediate r... |
|
|
Invention
|
Muscarinic m1 receptor positive allosteric modulators. The present invention relates to compounds... |
|
|
Invention
|
Triple combination of histamine-3 receptor inverse agonists, acetylcholinesterase inhibitors and ... |
|
|
Invention
|
Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitors. 3R) in... |
|
2016
|
Invention
|
Combination of pure 5-ht6 receptor antagonists with nmda receptor antagonist. The present inventi... |
|
|
Invention
|
6 receptor antagonists, acetylcholinesterase inhibitors and nmda receptor antagonist. The present... |
